Table of Content

Open Access iconOpen Access

ARTICLE

ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy

Huimin Zhang*†, Yuhui Pang, Chuanbao Ma, Jianying Li, Huaquan Wang*, Zonghong Shao*

* Department of Hematopathology, Tianjin Medical University General Hospital, Tianjin, P.R. China
† Department of Hematology, Shijiazhuang Ping’an Hospital, Shijiazhuang, Hebei, P.R. China

Oncology Research 2018, 26(3), 421-429. https://doi.org/10.3727/096504017X15049221237147

Abstract

Resistance to bortezomib (BZ) is the major problem that largely limits its clinical application in multiple myeloma treatment. In the current study, we investigated whether ClC5, a member of the chloride channel family, is involved in this process. The MTT assay showed that BZ treatment decreased cell viability in three multiple myeloma cell lines (ARH77, U266, and SKO-007), with IC50 values of 2.83, 4.37, and 1.91 nM, respectively. Moreover, BZ increased the conversion of LC3B-I to LC3B-II and expressions of beclin-1 and ATG5, concomitantly with a decreased p62 expression. Pharmacological inhibition of autophagy with 3-MA facilitated cell death in response to BZ treatment. Additionally, BZ increased ClC5 protein expression in ARH77, U266, and SKO-007 cells. Knockdown of ClC5 with small interfering RNA sensitized cells to BZ treatment, and upregulation of ClC5 induced chemoresistance to BZ. Furthermore, ClC5 downregulation promoted BZ-induced LC3B-I to LC3B-II conversion and beclin-1 expression, whereas overexpression of ClC5 showed the opposite results in ARH77 cells. Finally, BZ induced dephosphorylation of AKT and mTOR, which was significantly attenuated by ClC5 inhibition. However, ClC5 upregulation further enhanced AKT and mTOR dephosphorylation induced by BZ. Our study demonstrates that ClC5 induces chemoresistance of multiple myeloma cells to BZ via increasing prosurvival autophagy by inhibiting the AKT–mTOR pathway. These data suggest that ClC5 may play a critical role in future multiple myeloma treatment strategies.

Keywords


Cite This Article

APA Style
Zhang, H., Pang, Y., Ma, C., Li, J., Wang, H. et al. (2018). Clc5 decreases the sensitivity of multiple myeloma cells to bortezomib via promoting prosurvival autophagy. Oncology Research, 26(3), 421-429. https://doi.org/10.3727/096504017X15049221237147
Vancouver Style
Zhang H, Pang Y, Ma C, Li J, Wang H, Shao Z. Clc5 decreases the sensitivity of multiple myeloma cells to bortezomib via promoting prosurvival autophagy. Oncol Res. 2018;26(3):421-429 https://doi.org/10.3727/096504017X15049221237147
IEEE Style
H. Zhang, Y. Pang, C. Ma, J. Li, H. Wang, and Z. Shao "ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy," Oncol. Res., vol. 26, no. 3, pp. 421-429. 2018. https://doi.org/10.3727/096504017X15049221237147



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 52

    View

  • 38

    Download

  • 0

    Like

Share Link